Literature DB >> 8932760

Toxoplasma gondii: evidence for interleukin-12-dependent and-independent pathways of interferon-gamma production induced by an attenuated parasite strain.

T Scharton-Kersten1, P Caspar, A Sher, E Y Denkers.   

Abstract

Immunity in mice infected with Toxoplasma gondii is dependent upon the ability to generate protective levels of the cytokine IFN-gamma. In this report, we present evidence that the attenuated vaccine strain, ts-4, induces the latter cytokine by both IL-12-dependent and -independent pathways. In contrast, strain ME49 appears to induce IFN-gamma wholly in dependence upon IL-12. Thus, 88% of wildtype C57BL/6 mice treated with anti-IL-12 mAb survive ts-4 infection, unlike similarly treated ME49-infected animals. Moreover, while anti-IL-12 treatment reduced early IFN-gamma and nitric oxide production to background levels in ts-4-infected scid animals, the same treatment in infected C57BL/6 mice had no effect on production of the latter mediators. In addition, we found that anti-IL-12 treatment induces 100% mortality in CD(4+)-deficient MHC class II knockout mice infected with ts-4. Finally, production of nitric oxide (a molecule implicated in parasite control) was abrogated in ts-4-infected scid mice following depletion of IFN-gamma producing NK cells. Together, our results suggest that ts-4 induces IL-12-dependent and -independent IFN-gamma production in normal mice, but ME49 induces the latter cytokine only in dependence upon IL-12. Our data, furthermore, implicate involvement of T cells in the IL-12-independent component of the IFN-gamma response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8932760     DOI: 10.1006/expr.1996.0096

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  16 in total

1.  CD40 restrains in vivo growth of Toxoplasma gondii independently of gamma interferon.

Authors:  Carlos S Subauste; Matthew Wessendarp
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

Review 2.  Innate immunity to Toxoplasma gondii infection.

Authors:  Felix Yarovinsky
Journal:  Nat Rev Immunol       Date:  2014-02       Impact factor: 53.106

Review 3.  The immunology of parasite infections in immunocompromised hosts.

Authors:  T Evering; L M Weiss
Journal:  Parasite Immunol       Date:  2006-11       Impact factor: 2.280

Review 4.  The CD8 T-cell road to immunotherapy of toxoplasmosis.

Authors:  Rajarshi Bhadra; Jason P Gigley; Imtiaz A Khan
Journal:  Immunotherapy       Date:  2011-06       Impact factor: 4.196

5.  Limited interleukin-18 response in Salmonella-infected murine macrophages and in Salmonella-infected mice.

Authors:  A Elhofy; K L Bost
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

Review 6.  Innate responses to Toxoplasma gondii in mice and humans.

Authors:  Reed Pifer; Felix Yarovinsky
Journal:  Trends Parasitol       Date:  2011-09

7.  Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii.

Authors:  G Cai; R Kastelein; C A Hunter
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

8.  Salmonella typhimurium infection in mice induces nitric oxide-mediated immunosuppression through a natural killer cell-dependent pathway.

Authors:  M G Schwacha; J J Meissler; T K Eisenstein
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  Cell-mediated immunity to Toxoplasma gondii develops primarily by local Th1 host immune responses in the absence of parasite replication.

Authors:  Jason P Gigley; Barbara A Fox; David J Bzik
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

Review 10.  Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection.

Authors:  E Y Denkers; R T Gazzinelli
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.